Bruce Roth - Senior Vice President, Small Molecule Drug Discovery

Bruce Roth

Senior Vice President, Small Molecule Drug Discovery

"It is my desire to continue building our world-class Small Molecule Drug Discovery organization to enable Genentech to help as many patients as possible."
Years at Genentech
Awards & Honors

I joined Genentech in May 2007 to lead the Small Molecule Discovery Chemistry Department after 25 years at the Pfizer Ann Arbor site, the last seven as Vice President of Chemistry. I was attracted to Genentech because of its rich culture of scientific excellence and dedication to innovative, ground-breaking research driven by the needs of patients.

What I have seen at Genentech during my tenure is a real commitment to discovering and developing potential therapies for difficult, life-threatening diseases where medical need is high and often patients are desperate for new medical advances. This commitment is a distinguishing feature that attracted me to Genentech.

Featured Publication

The Relationship Between Tissue Selectivity and Lipophilicity for Inhibitors of HMG-CoA Reductase.

J. Med. Chem. 1991, 34, 463-6.

Roth BD, Bocan TMA, Blankley CJ, Chucholowski AW, Creger PL, Creswell MW, Ferguson E, Newton RS, O'Brien P, Picard JA, Roark WH, Sekerke CS, Sliskovic DR, Wilson MW.